Geron Corp (GERN)

1.22 -0.01  -0.81% NASDAQ Jul 30, 20:00 USD
View Full Chart
Price Chart
View All GERN News

News

View All Events

Events

Date Type Description
08/06/2021 Earnings Results Q2 2021 Earnings Results
08/06/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
05/10/2021 Earnings Results Q1 2021 Earnings Results
05/10/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
03/11/2021 Earnings Results Q4 2020 Earnings Results
03/11/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 Earnings Results Q3 2020 Earnings Results
11/05/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
08/06/2020 16:30 EST Earnings Calls Q2 2020 Earnings Call
08/06/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses global rights to this drug.
  • URL: https://www.geron.com
  • Investor Relations URL: http://ir.geron.com
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 06, 2021
  • Last Earnings Release: May. 10, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.